harvard pilgrim glp 1 Point32Health reports hefty losses in 2025 driven by GLP-1 weight-loss drugs Insurance coverage just changed for

ATLANTA A once-daily oral nonpeptide GLP-1 conferred significant improvements in body weight, HbA1c and other cardiometabolic parameters for adults with obesity and type 2 diabetes, according to findings from the ATTAIN-2 trial

If you are taking Zepbound, Mounjaro, Ozempic, or Wegovy, this heartfelt story will remind you that someone may be cheering for you more than you realize

Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1)

This guide walks you through how to inject tirzepatide using either a pen or a vial and explains where to inject it for maximum effectiveness, plus tips to help you feel confident every step of the way

Exenatide Activates the APPL1-AMPK-PPAR Axis to Prevent Diabetic Cardiomyocyte Apoptosis

A plain bowl of greens usually wont provide enough protein or calories